Jamjoom Pharmaceuticals Factory Co (SAU:4015) Beta: N/A (As of Jun. 29, 2026)


SAU:4015 Jamjoom Pharmaceuticals Factory Co SAU:4015
73 GF Score
Price ﷼158.40
GF Value ﷼181.57
Valuation Modestly Undervalued
! 2 Warning Signs
View Full Analysis

What is Jamjoom Pharmaceuticals Factory Co Beta?

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. As of today (2026-06-29), Jamjoom Pharmaceuticals Factory Co's Beta is Not available.

Jamjoom Pharmaceuticals Factory Co  (SAU:4015) Beta Explanation

Beta is a measure of the volatility, or systematic risk, of a security or a portfolio in comparison to the market as a whole. We usually compare beta to 1. A beta of 1 indicates that the security's price will move with the market. A beta of less than 1 means that the security will be less volatile than the market. A beta of greater than 1 indicates that the security's price will be more volatile than the market.

Beta is primarily used in the Capital Asset Pricing Model (CAPM) to calculate the Cost of Equity, which can be used in the calculation of WACC %. The formula of Cost of Equity is:
Cost of Equity = Risk-Free Rate of Return + Beta of Asset * (Expected Return of the Market - Risk-Free Rate of Return)

Jamjoom Pharmaceuticals Factory Co Beta Related Terms

Jamjoom Pharmaceuticals Factory Co Beta Historical Data

* Premium members only.

The historical data trend for Jamjoom Pharmaceuticals Factory Co's Beta can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Jamjoom Pharmaceuticals Factory Co Beta Chart

Jamjoom Pharmaceuticals Factory Co Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Beta
Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00

Jamjoom Pharmaceuticals Factory Co Quarterly Data
Dec20 Jun21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Beta Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
SAU:4015
73GF Score
Jamjoom Pharmaceuticals Factory Co SAU:4015
Beta is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Jamjoom Pharmaceuticals Factory Co Beta Calculation

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. A stock's beta can be calculated by dividing the product of the covariance of the individual stock's returns and the market's returns by the variance of the market's returns over a specified period. Basically, GuruFocus uses the returns calculated over three-year period.

Is Jamjoom Pharmaceuticals Factory Co (SAU:4015) Overvalued in 2026?

Based on GuruFocus' analysis, Jamjoom Pharmaceuticals Factory Co stock appears to be undervalued. The current stock price of ﷼158.40 is trading 12.8% below its estimated GF Value™ of ﷼181.57. GuruFocus considers Jamjoom Pharmaceuticals Factory Co to be Modestly Undervalued.

Key valuation signals for SAU:4015:

  • Beta: N/A
  • GF Value™: ﷼181.57 vs. price of ﷼158.40 (12.8% below fair value)
  • GF Score™: 73/100 with 2 warning signs

No single metric tells the full story. See the SAU:4015 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Jamjoom Pharmaceuticals Factory Co Business Description

Address Corniche Road, P.O. Box No. 6267, 1234 Al Hamra District, Jeddah, SAU, 21442
Jamjoom Pharmaceuticals Factory Co is engaged in producing human medicines, nutraceuticals, antibiotics, general analgesics, medicines for treatment of cough, allergy, asthma, heart diseases, blood pressure, diarrhea, vomiting, ulcer and acidity, treatment of various skin infections, cancer diseases, eye drops and ointments and cosmeceuticals. Geographically the company has a presence in the Kingdom of Saudi Arabia, the Gulf, Iraq, Egypt, North Africa, and other export markets.
73GF Score

Get the complete analysis for SAU:4015

Beta is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

﷼158.40
Price
﷼181.57
GF Value